ClinicalTrials.gg
RecruitingNCT07671638ExHypUpdated Oct 23, 2026

Methodological Study of Exercise and Hypoxic Conditions in Healthy Subjects

An interventional study of Exercise and hypoxia in Healthy Subjects (HS), Exercise and Hypoxia, sponsored by University Hospital, Grenoble. Recruiting at 1 site in France. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-23.

Primary conditionHypoxiaRegistry: Motor ActivityReclassifiedWhy we changed it
Registry
Motor Activity — the first condition term the registry derived for this study.
ClinicalTrials.gg
Hypoxia
Why
  1. Motor Activity is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Hypoxia.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University Hospital, Grenoble · Not applicable, Interventional, and Basic science

Updated Oct 23, 2026Now RecruitingSite recruiting status changed+2 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
305
Allocation
Not applicable
Ages
18 Years to 55 Years
Sex
All
01

Study summary

The aim of this protocol is to assess physiological responses during various physical exercise protocols (whole-body exercise such as cycling or treadmill running, or localised exercise such as knee extension) and during inhalation of a gas mixtures with various oxygen contents (similar to exposure at high altitude).

02

Conditions studied

  • Healthy Subjects (HS)
  • Exercise
  • Hypoxia

Browse trials for

03

In context

Hypoxia Reclassified

1,076 studies on the registry are indexed under Hypoxia; 213 are open to participants now.

This study's planned enrollment of 305 is above the median of 45 across 769 interventional studies indexed under Hypoxia.

Browse Hypoxia studies →

Lead sponsor

University Hospital, Grenoble is the lead sponsor of 837 studies on the registry; 207 are open to participants now.

Compared within Hypoxia, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Motor Activity. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy male or female volunteers
  • Aged 18-55
  • \<30 kg/m²
  • Participants covered by a social security scheme
  • Participants capable of signing an form
  • Negative pregnancy test and highly effective for women of childbearing age

Exclusion criteria

Exclusion Criteria:

  • Cardiorespiratory, metabolic and neurological disorders, or other conditions assessed during the inclusion consultation that may affect physiological responses to exercise or hypoxia
  • Pharmacological treatment taken during the study, other than oral or implantable medication for female volunteers of childbearing age
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
305 participants (estimated)

Study arms

  • Experimental
    Exercise and hypoxia

    Exercise test performed while inhaling a gas mixture

    Combination Product: Exercise and hypoxia

Interventions

  • Combination productExercise and hypoxia

    Subjects will perform an exercise test while inhaling a hypoxic gas mixture

06

What researchers measure

Primary outcomes

  1. Muscle oxygenation

    Measured by NIRS in % saturation

    Time frame: During 5 minutes before starting the exercise test, continuously during the exercise test and during 10 minutes immediatly after the end of the exercise test

Secondary outcomes

  1. Gas exchange

    Oxygen consumption and cardon dioxide production measured at the mouth, measured in ml/min

    Time frame: During 5 minutes before starting the exercise test, continuously during the exercise test and during 10 minutes immediatly after the end of the exercise test

  2. Heart rate

    Measured by ECG in bpm

    Time frame: During 5 minutes before starting the exercise test, continuously during the exercise test and during 10 minutes immediatly after the end of the exercise test

  3. Limb blood flow

    Measured by Doppler ultrasound in ml/min

    Time frame: During 5 minutes before starting the exercise test, continuously during the exercise test and during 10 minutes immediatly after the end of the exercise test

07

Study locations

1 of 1 sites recruiting
  • CReSI (centre de recherche en santé intégrée)
    La Tronche, 38700, France
    Recruiting
08

References and documents

Publications

  • Mazzeo RS. Physiological responses to exercise at altitude : an update. Sports Med. 2008;38(1):1-8. doi: 10.2165/00007256-200838010-00001. PubMed 18081363 ↗
  • Hansford HJ, Wewege MA, Cashin AG, Hagstrom AD, Clifford BK, McAuley JH, Jones MD. If exercise is medicine, why don't we know the dose? An overview of systematic reviews assessing reporting quality of exercise interventions in health and disease. Br J Sports Med. 2022 Jun;56(12):692-700. doi: 10.1136/bjsports-2021-104977. Epub 2022 Feb 15. PubMed 35168956 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Oct 2031, 59 months after the start.

Of 321 non-industry interventional studies with no phase under Hypoxia, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 27. This study's planned 59 months is above that.

Counting every sponsor, half of 351 studies reached it within 12 months; a quarter within 3 and three quarters within 27.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 23, 2026: start Sep 2026 → Oct 2026 and primary completion Sep 2031 → Oct 2031.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 26, 2026
First posted
Jun 26, 2026
StartActual
Oct 19, 2026was Sep 2026
Primary completionEst.
Oct 15, 2031was Sep 2031
CompletionEst.
Mar 31, 2032
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 23, 2026
Sites
CReSI (centre de recherche en santé intégrée) is now Recruiting
Oct 23, 2026
Start date
Sep 15, 2026→Oct 19, 2026 (actual)
Oct 23, 2026
Primary completion
Sep 15, 2031→Oct 15, 2031
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    Not yet recruiting→Recruiting
    CReSI (centre de recherche en santé intégrée) is now Recruiting
    Start date Sep 15, 2026→Oct 19, 2026 (now actual)
    Primary completion Sep 15, 2031→Oct 15, 2031
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07671638
Collaborators
University Grenoble Alps
Responsible party
Sponsor
First posted
Jun 26, 2026
Start date
Oct 19, 2026
Primary completion
Oct 15, 2031 (estimated)
Completion
Mar 31, 2032 (estimated)
Last update
Oct 23, 2026

Study contacts

Samuel Vergès
Contact
sverges@chu-grenoble.fr
+33670395773

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion